Candriam Equities L Biotech.N USD Acc/ LU0133359157 /
NAV20/06/2024 | Chg.+5.3200 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
601.9800USD | +0.89% | reinvestment | Equity | Candriam ▶ |
Funds documents
Date | Document | Year | Language | Filesize |
---|---|---|---|---|
22/06/2024 | Public WebStation Live Factsheet | 2024 | English | - |
03/06/2024 | Prospectus | 2024 | English | 3,663.84 KB |
03/06/2024 | Prospectus | 2024 | German | 5,520.88 KB |
01/03/2024 | PRIIP Key Information Document | 2024 | English | 260.09 KB |
01/03/2024 | PRIIP Key Information Document | 2024 | German | 268.47 KB |
31/12/2023 | Account statment | 2023 | English | 5,416.37 KB |
31/12/2023 | Account statment | 2023 | German | 4,732.66 KB |
30/06/2023 | Semi-annual report | 2023 | English | 1,982.78 KB |
30/06/2023 | Semi-annual report | 2023 | German | 2,086.39 KB |
02/07/2022 | Key Investor Information | 2022 | English | 362.07 KB |
02/07/2022 | Key Investor Information | 2022 | German | 366.42 KB |